• managing pre-award feasibility assessments (enrollment benchmarking, competitive landscape analysis, enrollment scenarios development)• providing feasibility and country selection strategy/approach for requests for proposals (RFPs), requests for information (RFIs), paid feasibilities, and awarded trials in collaboration with the involved internal parties• establishing and maintaining effective working relationships with key leaders from the Therapeutic Area Management team, Medical Directors, and Business Development team members• Feasibility and Site Identification team trainingKey achievements:• I conducted department-level training in study protocol review from feasibility point of view with special focus on entry criteria, schedule of events, pre-treatment requirements, correct site profile selection, potential regulatory issues and other relevant definitive factors for study feasibility

Leading global site identification assessments (post-award feasibility assessments):- defining site identification strategy, - site profile analysis and site list development,- site identification questionnaire development- supervision of site identification team assigned to a project- project-specific financial management

• leading global site identification assessments (post-award feasibility)• leading global strategic feasibility in terms of proposal development and bid defense preparation• protocol review for medical and scientific soundness and revision of it if needed• study design improvement from feasibility point of view• schedule of events revision from medical point of view for budgeting purposes• projecting # of SAEs and SUSARs per study for budgeting purposes• performing protocol-specific training for the project team• investigator grant calculation at pre-award stage (using internal tools and Medidata)• country-level feasibility in Russia, Ukraine, Belarus, Georgia, Israel and Kazakhstan• identification of KOLs and potential sites, maintenance of relationships with them Therapeutic areas of my projects: Hematology, Clotting Disorders, Rare Diseases (including several GMO and gene therapy trials), Oncology, Infectious Diseases (antibiotics and antifungals), Inflammatory Bowel Diseases, Multiple Sclerosis Key achievements at PSI: Leading pre-award strategic feasibility projects - 35 Leading site identification& standalone feasibility projects - 7 Country-level feasibility requests - 464 Investigator grants calculation - 11 Bid defense participation - 2 • I became a department-level expert and primary contact person in strategic feasibility and site identification for clotting disorders, rare diseases and GMO/gene therapy trials. For my last project in rare clotting disorders I had to develop a disease severity classification (due to a lack of international guidelines) and key elements of study design • I played a key role in establishing a new business process – site identification • I improved an investigator grant template and investigator grant calculation process to make it less time-consuming, more efficient and transparent

• leading global strategic feasibility assessments in terms of proposal development and bid defense preparation • country-level feasibility in Russia, Ukraine, Belarus, Georgia • identification of KOLs and potential sites, maintenance of relationships with them

Treating patients in an outpatient setting (patient profile - Сardiology, Pulmonology, Gastroenterology and Infectious Diseases)

• teaching internal diseases, evidence-based medicine, medical massage and other subjects• performing lectures and practical classes at hospital• holding exams, including state graduation exams• scientific supervision of graduating students

• treatment of hospital patients (cardiology, pulmonology, endocrinology, urgent care, neurology)• management of staff activities

lymphodrenage and classic massage; participation in consultations on bodycare as part of a weight-loss program